Trial on Yijinjing Exercise for Sarcopenia Listed, Not Yet Recruiting

A clinical trial titled "Yijinjing Exercise for Musculoskeletal Health in Adults With Sarcopenia" was registered on October 21, 2026. The trial, listed under identifier NCT07871240, has a phase designation of NA. Its current status is not yet recruiting. No phase-specific dosing or results data have been reported for this study at this stage. The registration indicates the trial has been entered into the public database but has not yet begun enrolling participants. As a not yet recruiting study, no outcomes or interim findings are currently available to report. Interested parties can monitor the official trial listing for updates on recruitment status and study progress. This update pertains to the trial registration itself and does not include any efficacy or safety conclusions. The event record does not specify additional details such as sponsor, enrollment targets, or estimated completion date. For broader context on corticotropin, which is referenced in connection with this record, readers can consult the compound overview.